Trials / Sponsors / Daniel George, MD
Daniel George, MD
Academic / Other · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation Bladder Cancer | Phase 1 | 2020-06-01 |
| Terminated | A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prosta Prostate Cancer | Phase 1 | 2017-07-11 |
| Completed | Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant P Prostate Cancer | Phase 2 | 2017-07-10 |
| Completed | Pazopanib, Docetaxel, Prednisone Prostate Prostate Cancer | Phase 1 | 2011-06-01 |
| Completed | A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma Renal Cell Carcinoma | Phase 1 | 2008-10-01 |
| Completed | RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer Hormone Refractory Prostate Cancer | Phase 2 | 2005-08-01 |
| Completed | Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors Kidney Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2004-12-01 |